Insights On Upstream Manufacturing

  1. What To Look For In A Cell Culture Media Supplier 4/17/2026

    Choosing a cell culture media supplier is crucial in biopharmaceutical manufacturing. Explore five key factors to take into account when choosing a supplier and evaluating their capabilities.

  2. Automated T Cell Manufacturing From Start To Fill 4/17/2026

    Gain insight into how an automated, closed workflow can integrate T cell enrichment, activation, transduction, expansion, and formulation across fresh and frozen starting materials.

  3. CAR T Cell Generation From Cryopreserved Leukapheresis Products 4/17/2026

    A seven‑day CAR T cell manufacturing workflow shows how cryopreserved leukapheresis material can deliver high viability and strong antitumor activity, offering a more flexible path for production.

  4. How To Select The Right Platform For Your Vaccine Production Process 4/16/2026

    Evaluate surface treatments, scalability, and contamination risks to select the right adherent platform. Testing early ensures a seamless transition from benchtop to production.

  5. Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview 4/16/2026

    From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.

  6. How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up 4/16/2026

    Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing.

  7. Industrializing Cell Therapy With Perfusion 4/14/2026

    Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.

  8. Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter 4/9/2026

    Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.

  9. Scalable Biologics Production Trends: Featuring Omar Wahab 4/9/2026

    Listen in as Dr. Corey Stanton speaks with Dr. Omar Wahab, Vice President of Bioprocessing at Lonza, about the strategic role of cell culture media in scalable biologics manufacturing.

  10. From Fermentation To Vaccination 4/8/2026

    Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.